Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra

Neuroscience Letters

Volumn 396, Issue 3, 2006, Pages 187-191

  Yamamoto, Shoji ^a,b   Fukae, Jiro ^a   Mori, Hideo ^a   Mizuno, Yoshikuni ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Diffuse Lewy body disease; Immunohistochemistry; Lewy bodies; Parkinson's disease; Vesicular monoamine transporter 2

Indexed keywords

CHROMOGRANIN A; POLYCLONAL ANTIBODY; SYNAPTOPHYSIN; VESICULAR MONOAMINE TRANSPORTER 2;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CORTEX; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MESENCEPHALON; MICROSCOPY; NERVE DEGENERATION; NEURITE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; SYNAPSE VESICLE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; SENILE PLAQUES; SUBSTANTIA NIGRA; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 33644669577     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.068     Document Type: Article

References (18)

1. C. Bancher, H. Lassmann, H. Budka, K. Jellinger, I. Grundke-Iqbal, K. Iqbal, G. Wiche, F. Seitelberger, and H.M. Wisniewski An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination J. Neuropathol. Exp. Neurol. 48 1989 81 93
2. L.S. Forno, and R.L. Norville Ultrastructure of Lewy bodies in the stellate ganglion Acta Neuropathol. 34 1976 183 197
3. T. Fukuda, J. Tanaka, K. Watabe, R.T. Numoto, and M. Minamitani Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease Acta Pathol. Jpn. 43 1993 545 551
4. K.A. Harrington, S.J. Augood, A.E. Kingsbury, O.J.F. Foster, and P.C. Emson Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease Mol. Brain Res. 36 1996 157 162
5. E. Iseki, W. Marui, H. Sawada, K. Ueda, and K. Kosaka Accumulation of human α-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies Neurosci. Lett. 290 2000 41 44
6. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
7. S. Lehericy, J.P. Brandel, E.C. Hirsch, P. Anglade, J. Villares, D. Scherman, C. Duyckaerts, F. Javoy-Agid, and Y. Agid Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography Brain Res. 659 1994 1 9
8. + toxicity encodes a vesicular amine transporter Cell 70 1992 539 551
9. J. Lotharius, S. Barg, P. Wiekop, C. Lundberg, H.K. Raymon, and P. Brundin Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line J. Biol. Chem. 277 2002 38884 38894
10. G.W. Miller, J.D. Erickson, J.T. Perez, S.N. Penland, D.C. Mash, D.B. Rye, and A.I. Levey Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease Exp. Neurol. 156 1999 138 148
11. M.J. Nirenberg, J. Chan, Y. Liu, R.H. Edwards, and V.M. Pickel Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine J. Neurosci. 16 1996 4135 4145
12. M. Nishimura, H. Tomimoto, T. Suenaga, S. Nakamura, Y. Namba, K. Ikeda, I. Akiguchi, and J. Kimura Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains Brain Res. 634 1994 339 344
13. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G.D. Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
14. S. Shimohama, G. Perry, P. Richey, T. Takenawa, P.J. Whitehouse, K. Miyoshi, T. Suenaga, S. Matsumoto, M. Nishimura, and J. Kimura Abnormal accumulation of phospholipase C-δ in filamentous inclusions of human neurodegenerative disease Neurosci. Lett. 162 1993 183 186
15. M.G. Spillantini, M.L. Schmidt, V.M.Y. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert α-Synuclein in Lewy bodies Nature 388 1997 839 840
16. D. Sulzer, and L. Zecca Intraneuronal dopamine-quinone synthesis: a review Neurotox. Res. 3 2000 181 195
17. K. Wakabayashi, H. Takahashi, K. Obata, and F. Ikuta Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease Neurosci. Lett. 138 1992 237 240
18. I. Watanabe, E. Vachal, and T. Tomita Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study Acta Neuropathol. 39 1977 173 175